Cargando…

Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology

Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus (DM) causing vision impairment even at young ages. There are numerous mechanisms involved in its development such as inflammation and cellular degeneration leading to endothelial and neural damage. These mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cecilia, Olvera-Montaño, José Alberto, Castellanos-González, José, Navarro-Partida, Ernesto Germán, Cardona-Muñoz, Ana Karen, López-Contreras, Luis Miguel, Roman-Pintos, Ricardo Raúl, Robles-Rivera, Adolfo Daniel, Rodríguez-Carrizalez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710812/ https://www.ncbi.nlm.nih.gov/pubmed/31511825 http://dx.doi.org/10.1155/2019/8562408

Ejemplares similares

Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation
por: Robles-Rivera, Ricardo Raúl, et al.
Publicado: (2020)

Importance of the Use of Oxidative Stress Biomarkers and Inflammatory Profile in Aqueous and Vitreous Humor in Diabetic Retinopathy
por: López-Contreras, Ana Karen, et al.
Publicado: (2020)

Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function
por: Román-Pintos, Luis Miguel, et al.
Publicado: (2016)

Effect of statins on oxidative DNA damage in diabetic polyneuropathy
por: Carrillo-Ibarra, Sandra, et al.
Publicado: (2018)

Toll-Like Receptor-1 and Receptor-2 and Beta-Defensin in Postcholecystectomy Bile Duct Injury
por: Miranda-Díaz, Alejandra Guillermina, et al.
Publicado: (2015)

Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2014)

The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2015)

The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2016)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
por: Hernández-Ojeda, Jaime, et al.
Publicado: (2014)

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Villegas-Rivera, Geannyne, et al.
Publicado: (2015)

Pathophysiology of Diabetic Retinopathy
por: Tarr, Joanna M., et al.
Publicado: (2013)

Pathophysiology of retinopathy of prematurity
por: Strube, Yi Ning J., et al.
Publicado: (2022)

Diabetic Retinopathy: Pathophysiology and Treatments
por: Wang, Wei, et al.
Publicado: (2018)

Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy
por: Qian, Haohua, et al.
Publicado: (2011)

Pathophysiology of Diabetic Retinopathy: The Old and the New
por: Kusuhara, Sentaro, et al.
Publicado: (2018)

The pathophysiological mechanisms underlying diabetic retinopathy
por: Wei, Lindan, et al.
Publicado: (2022)

Impact of Pharmaceutical Education on Medication Adherence and Its Clinical Efficacy in Patients with Type 2 Diabetes and Systemic Arterial Hypertension
por: Contreras-Vergara, Abelardo, et al.
Publicado: (2022)

New Developments in the Pathophysiology and Management of Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate
por: Mercado-Sesma, Arieh, et al.
Publicado: (2017)

Toll-Like Receptors in Secondary Obstructive Cholangiopathy
por: Miranda-Díaz, A. G., et al.
Publicado: (2011)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects
por: Tecilazich, Francesco, et al.
Publicado: (2020)

The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges
por: Galderisi, Silvana, et al.
Publicado: (2023)

Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
por: Whitehead, Michael, et al.
Publicado: (2018)

Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
por: Nian, Shen, et al.
Publicado: (2021)

Commentary: Recent concepts of pathophysiology and advancements in treatment strategies of diabetic retinopathy
por: Singh, Ankur, et al.
Publicado: (2021)

Reduced Systolic Volume: Main Pathophysiological Mechanism in Patients with Orthostatic Intolerance?
por: Távora-Mehta, Maria Zildany P., et al.
Publicado: (2016)

A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology
por: Berkenstock, Meghan, et al.
Publicado: (2020)

Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective
por: Bunch, Katharine L., et al.
Publicado: (2022)

Selective decrease in alpha(1)-antitrypsin levels in diabetic retinopathy: Could the levels of it be playing a role in the pathophysiology of diabetic retinopathy?
por: Kunder, Mamatha, et al.
Publicado: (2022)

Ischemic Retinopathies: Oxidative Stress and Inflammation
por: Rivera, José Carlos, et al.
Publicado: (2017)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

The Role of Microglia in Diabetic Retinopathy
por: Grigsby, Jeffery G., et al.
Publicado: (2014)

Pathophysiology and Management of Fatigue in Neuromuscular Diseases
por: Torri, Francesca, et al.
Publicado: (2023)

Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders- a review
por: Ayoobi, Fatemeh, et al.
Publicado: (2017)

Evaluation of the Relationship Between Diabetic Macular Edema and Renal Function in a Latino Population
por: Torres-Arellano, José M., et al.
Publicado: (2023)

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
por: Muñoz-Villegas, Patricia, et al.
Publicado: (2021)

Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate
por: Sánchez‐Ríos, Alejandra, et al.
Publicado: (2022)

Differentiating Microaneurysm Pathophysiology in Diabetic Retinopathy Through Objective Analysis of Capillary Nonperfusion, Inflammation, and Pericytes
por: An, Dong, et al.
Publicado: (2022)

The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases
por: García-Sánchez, Andrés, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kb6pno7nnoi8asd2onrbv7658u